Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots
Open Access
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 2 (4) , 696-707
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Antithrombin-Independent Effects of Heparins on Fibrin Clot NanostructureArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Dabigatran EtexilateCirculation, 2011
- The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by α2‐macroglobulin‐thrombinJournal of Thrombosis and Haemostasis, 2010
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran EtexilateClinical Pharmacokinetics, 2008
- Preclinical and Clinical Characteristics of Rivaroxaban: A Novel, Oral, Direct Factor Xa InhibitorSeminars in Thrombosis and Hemostasis, 2007
- Thrombelastography/thromboelastometryClinical and Laboratory Haematology, 2005
- In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profileThrombosis and Haemostasis, 2004
- Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agentExpert Opinion on Investigational Drugs, 2002
- The Pharmacokinetics of Fondaparinux Sodium in Healthy VolunteersClinical Pharmacokinetics, 2002
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983